Trials / Conditions / Churg-Strauss Syndrome

Churg-Strauss Syndrome

26 registered clinical trials studyying Churg-Strauss Syndrome — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Trial of Efficacy and Safety of NS-229 Versus Placebo in Patients With Eosinophilic Granulomatosis With Polyan NCT06046222	NS Pharma, Inc.	Phase 2
Unknown	Hydroxychloroquine in ANCA Vasculitis Evaluation NCT04316494	Guy's and St Thomas' NHS Foundation Trust	Phase 4
Completed	Mepolizumab Long-term Study to Assess Real World Safety and Effectiveness of Eosinophilic Granulomatosis With NCT04551989	GlaxoSmithKline	—
Completed	Identification of Autoantigens in EGPA and Severe Eosinophilic Asthma NCT04671446	Queen Mary University of London	—
Completed	NUCALA® Special Drug Use Investigation (EGPA, Long-term) NCT03557060	GlaxoSmithKline	—
Recruiting	VCRC Tissue Repository NCT02967068	University of Pennsylvania	—
Completed	Eosinophilic Granulomatosis With Polyangiitis Cohort NCT03036670	Portsmouth Hospitals NHS Trust	—
Terminated	Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome NCT02728271	Mounzer Agha	EARLY_Phase 1
Completed	Long-term Access Program (LAP) of Mepolizumab for Subjects Who Participated in Study MEA115921 NCT03298061	GlaxoSmithKline	Phase 3
Completed	VCRC Patient Contact Registry Patient-Reported Data Validation Study NCT02190942	University of South Florida	—
Completed	A Study to Investigate Mepolizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis NCT02020889	GlaxoSmithKline	Phase 3
Unknown	PRO Development for ANCA Associated Vasculitis NCT01729624	University of Oxford	—
Completed	Educational Needs of Patients With Systemic Vasculitis NCT02190929	University of South Florida	—
Completed	Vasculitis Illness Perception (VIP) Study NCT02190916	University of South Florida	—
Completed	Reproductive Health in Men and Women With Vasculitis NCT02176070	University of South Florida	—
Unknown	American College of Rheumatology/European League Against Rheumatism (ACR/EULAR) Diagnostic and Classification NCT01066208	University of Oxford	—
Completed	Safety and Efficacy Study of Mepolizumab in Churg Strauss Syndrome NCT00716651	University Hospital Schleswig-Holstein	Phase 2
Completed	Mepolizumab As a Steroid-sparing Treatment Option in the Churg Strauss Syndrome NCT00527566	Brigham and Women's Hospital	Phase 1 / Phase 2
Terminated	Rituxan in Churg Strauss Syndrome With Renal Involvement NCT00424749	Fernando Fervenza	Phase 2
Recruiting	Longitudinal Study for Eosinophilic Granulomatosis With Polyangiitis NCT00315380	University of Pennsylvania	—
Completed	Treatment of Necrotizing Vasculitides for Patients Older Than 65 Years NCT00307671	Assistance Publique - Hôpitaux de Paris	Phase 4
Completed	RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing Vasculitides NCT00307593	Assistance Publique - Hôpitaux de Paris	N/A
Completed	Anti-Interleukin-5 (IL-5) Study for Hypereosinophilic Syndrome NCT00266565	Children's Hospital Medical Center, Cincinnati	Phase 1 / Phase 2
Unknown	Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases NCT00006055	Fairview University Medical Center	N/A
Unknown	CHUSPAN SCS BP Treatment of Churg-Strauss Syndrome Without Poor-Prognosis Factors NCT00399399	Hospices Civils de Lyon	Phase 4
Unknown	Cyclophosphamide Versus Methotrexate for Remission Maintenance in Systemic Necrotizing Vasculitides NCT00751517	University of Parma	Phase 2